Marc Sernel concentrates his practice on patent and other technology-related litigation with a particular focus on chemical, biotechnology, and computer science-related matters. Representative of Marc’s experience in the biotech area are patent matters involving DNA microarrays, intracellular transcription factors, and transgenic plant technology. Praised in the Legal 500 for his “excellent legal instincts,” Marc has acted as lead counsel and handled all aspects of trial work in district courts and at the International Trade Commission, and has successfully argued at the Federal Circuit.


Thought Leadership


“Privilege, Waiver and Confidentiality,” American Conference Institute’s Freedom To Operate — Analysis, Opinion Writing, and Strategies for Minimizing Risks in the Pharmaceutical, Biotech, and Chemical Industries, New York, Nov. 12, 2003.


Admissions & Qualifications

  • 1997Illinois


  • Loyola University Chicago School of LawJ.D.magna cum laude1997

    Ranked 1st in Class of 220

    Loyola Law Journal

  • University of Illinois at Urbana-ChampaignB.S., Chemical Engineering1992
    Engineering Open House Chairman